Repare Therapeutics Shares Higher Premarket 10%+ Owner Mark Lampert Reported Purchase Of 783,709 Shares @ Avg Price Of $3.60/Share in Form 4 Filing On Friday
Portfolio Pulse from Charles Gross
Mark Lampert, a 10%+ owner of Repare Therapeutics, has reported the purchase of 783,709 shares at an average price of $3.60 per share in a Form 4 filing on Friday. This has led to a premarket increase in Repare Therapeutics' shares.
November 06, 2023 | 10:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repare Therapeutics' shares are up in premarket trading after Mark Lampert, a 10%+ owner, reported buying 783,709 shares at an average price of $3.60 per share.
Insider buying often signals confidence in a company's future prospects, which can positively impact the stock price. In this case, Mark Lampert, a significant owner of Repare Therapeutics, has purchased a large number of shares, indicating his belief in the company's potential. This has led to an increase in Repare Therapeutics' share price in premarket trading.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100